The latest dustup over the rising price of insulin has found its way to a federal court, where several consumers are accusing the three biggest manufacturers — Sanofi, Eli Lilly, and Novo Nordisk — of running a coordinated scheme that has caused patients economic harm.

The lawsuit arrives two months after Senator Bernie Sanders (D-Vt.) and Representative Elijah Cummings (D-Md.) asked the Department of Justice and the Federal Trade Commission to investigate the companies for price collusion. They cited a pattern in which prices for insulin often rose in tandem over several years and expressed concern the drug makers conspired to raise prices and, as a result, drove up the cost for patients and taxpayers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I BEG my Doctor for samples or expired samples as I am unable to afford the Co-Pays on my Prescriptions now. $900.00 per month equals $10,800.00 per year, could you really do this, it would help to cut down on the population for sure. This would be one SUICIDE, I am sure Christ would not consider to be a SIN !!!!!

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy